Novel method to detect, isolate, and culture prostate culturing circulating tumor cells

Area of Science:

• Oncology
• Cell Biology
• Biotechnology

Background:

• Detecting and culturing circulating tumor cells (CTCs) is crucial for early metastasis diagnosis, monitoring treatment efficacy, and drug screening.
• Current FDA-approved methods rely on antibody binding, which has limitations due to antibody variability and size mismatches.
• Advanced methods for CTC detection and culturing are urgently needed.

Purpose of the Study:

• To develop a novel method for detecting and culturing CTCs using cell-cell interactions.
• To overcome the limitations of traditional antibody-based CTC detection methods.
• To establish a platform for individualized cancer medicine.

Main Methods:

• Prostate cancer tissue was digested and cultured.
• Cancer stromal cells were isolated, labeled (DAPI), and incubated with whole blood from cancer-bearing mice.
• Attached CTCs were detected, isolated, cultured, and established into individual cell lines.

Main Results:

• Five prostate cancer cell clones were successfully cultured.
• One clone (Clone-1) expressed key stromal cell markers (CD133, α2β1 integrin, CD44) and EpCAM.
• Clone-1 cells acted as 'bait' to capture and culture CTCs from mouse blood, establishing single-cell derived lines.

Conclusions:

• A novel CTC detection and culturing method based on cell-cell interaction, distinct from antibody-based methods, was developed.
• This approach shows potential for early cancer metastasis detection and monitoring chemotherapy efficacy.
• Efficiently cultured CTCs enable single-clone analysis and anti-cancer drug screening for personalized medicine.